DEVELOPMENT OF TOLL-LIKE RECEPTOR AGONISTS TO STRENGTHEN SUBLINGUAL VACCINES.

NIH RePORTER · NIH · N43 · $599,582 · view on reporter.nih.gov ↗

Abstract

The contract supports the development of a vaccine adjuvant for sublingual use. The adjuvant development activities will occur within the context of an influenza vaccine.

Key facts

NIH application ID: 10688744
Project number: 75N93022C00005-0-9999-1
Recipient: VIRTICI, LLC
Principal Investigator: NEIL FANGER
Activity code: N43
Funding institute: NIH
Fiscal year: 2022
Award amount: $599,582
Award type: —
Project period: 2022-01-10 → 2024-01-09